Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Mereo Biopharma Group Plc (MREO) has shared an announcement.
Mereo BioPharma Group plc has partnered with key underwriters for a public offering of 12.5 million American Depositary Shares at $3.99 each, representing five ordinary shares per ADS. The company anticipates a net gain of roughly $45.9 million after expenses and expects the offering to close by June 17, 2024. This move is backed by a shelf registration statement with the SEC, and the underwriters are provided with customary indemnification rights. A recent press release details the offering’s pricing, underscoring the company’s proactive disclosure to investors.
Find detailed analytics on MREO stock on TipRanks’ Stock Analysis page.
